Livongo IPO gives confidence boost to Asia's digital health scene
Investors could be more bullish on exit viability, business model of similar Asian digital health players
Add BT as a preferred source
Sharanya Pillai
Singapore
THE exuberant market response to the listing of US-based startup Livongo Health could provide a shot in the arm for Asian startups similarly focused on behavioural and preventive medicine, reckon investors who spoke to The Business Times.
Livongo, which debuted on the Nasdaq on Thursday, saw its share price surge 36 per cent to US$38.10 on the first day of trading, giving it a market cap of US$3.46 billion. This is more than four times its US$800 million valuation as at April.
TRENDING NOW
Wealth of Singapore’s 50 richest diverges as OCBC, Sheng Siong boom offsets tech slide
Massive tax bill clouds sale of Singapore land by Malaysian king’s son
Canada’s fight with the US has far bigger stakes than trade
What’s luck got to do with it? Everything, says Malaysian jewellery king Tomei’s chief
